The latest price target for Alvotech (NASDAQ:ALVO) was reported by UBS on February 14, 2025. The analyst firm set a price target for $18.00 expecting ALVO to rise to within 12 months (a possible 53.13% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Alvotech (NASDAQ:ALVO) was provided by UBS, and Alvotech initiated their buy rating.

The last upgrade for Alvotech happened on January 29, 2024 when Barclays raised their price target to $17. Barclays previously had an equal-weight for Alvotech.

The last downgrade for Alvotech happened on September 6, 2022 when Citigroup changed their price target from $12 to $5 for Alvotech.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alvotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alvotech was filed on February 14, 2025 so you should expect the next rating to be made available sometime around February 14, 2026.

While ratings are subjective and will change, the latest Alvotech (ALVO) rating was a initiated with a price target of $0.00 to $18.00. The current price Alvotech (ALVO) is trading at is $11.76, which is within the analyst’s predicted range.